Downregulation of Linc00173 increases BCL2 mRNA stability via the miR-1275/PROCA1/ZFP36L2 axis and induces acquired cisplatin resistance of lung adenocarcinoma

BACKGROUND: LINC00173 had been reported as a cisplatin (cis-diamminedichloroplatinum, DDP) chemotherapy-resistant inducer in small-cell lung cancer (SCLC) and lung squamous cell carcinoma (LUSC). This study aimed to display reverse data for LINC00173 as a DDP chemosensitivity-inducing factor in lung...

Descripción completa

Detalles Bibliográficos
Autores principales: Tao, Xingyu, Li, Yang, Fan, Songqing, Wu, Liyang, Xin, Jianyang, Su, Yun, Xian, Xiaoyang, Huang, Yingying, Huang, Rongquan, Fang, Weiyi, Liu, Zhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830831/
https://www.ncbi.nlm.nih.gov/pubmed/36627670
http://dx.doi.org/10.1186/s13046-022-02560-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830831/
https://www.ncbi.nlm.nih.gov/pubmed/36627670
http://dx.doi.org/10.1186/s13046-022-02560-6

Ejemplares similares